Type2 Diabetes
Conditions
Interventions
None listed
Sponsors
Japan Physicians Association
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The patient of Type2 diabetes 2. The age between 65-90 years (Male and Female) 3. The patient who is insufficient glycemic control being diet and exercise therapy alone or, in combination with drug therapy 4. The patient who newly starts diabetes medical treatment with sitagliptin
Exclusion criteria
Exclusion criteria: 1. The patient who has an anamnesis of sitaglitin allergy 2. The patient who has used incretin related drug in the past 3 month 3. The patient who has severe ketosis, diabetic coma or pre coma in the past 6 month 4. The patient has severe infection, before or after operation or severe external injury 5. The patient who has severe renal dysfanction 6. The patient of Type1 diabetes 7. The patient who is undertaking with glinide class 8. The patient is not allowed to this study by attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c GA Side effect, complication and its incidence rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight, Blood pressure, Fasting plasma glucose, Compliance of diet therapy, Compliance of exercise therapy, Dose of sitagliptin, Concomitant drug for diabetic treatment, Reason for change agents, Concomitant drug for complication, GOT(AST), GPT(ALP), gammaGTP, U-Cre, U-Alb, Urine protein, Questionnaire | — |
Countries
Japan
Contacts
Public ContactHiroki Takyama
Soiken Inc. Division of Clinical Study Support
Outcome results
None listed